Psychedelic Science in the 21st Century 2010 (Podcast)


April 15-18, 2010 • San Jose, California

Psychedelic Science brought together international experts to present on psychedelic research and psychedelic psychotherapy topics for the largest conference dedicated solely to psychedelics in the U.S. in 17 years. There were three full days of programming with concurrent tracks exploring clinical and spiritual applications, issues relevant to healthcare professionals, and social and cultural issues surrounding the therapeutic and recreational uses of psychedelics.

This conference was a huge success. We brought researchers, medical doctors, psychologists, other medical and health professionals, and people with a general interest in psychedelics from around the globe to our sold out event. If you missed it, we are planning to have another conference in a few years. We encourage you to sign up for MAPS’ free email updatesand we invite you to join us in our research by becoming a MAPS member. DVDs and CDs from the conference can be purchased online at www.conferencerecording.com. In the meantime, be sure to check out all of the great media generated about the conference below.

Psychedelic Science featured dozens of world-renowned presenters including:

Stanislav Grof, M.D., co-founder of transpersonal psychology

Michael Mithoefer, M.D., principal investigator for MAPS flagship US MDMA/PTSD study

Andrew Weil, M.D., integrative medicine proponent

Alex and Allyson Grey, visionary artists

David Nichols, Ph.D., medicinal chemist and pharmacologist

Charles Grob, M.D., UCLA psilocybin researcher

Robert Jesse, founder of Council on Spiritual Practices (CSP)

Roland Griffiths, Ph.D., principal investigator for CSP’s Johns Hopkins psilocybin study

Ralph Metzner, Ph.D., consciousness researcher and psychotherapist

Earth and Fire Erowid, founders of Erowid.org

Rick Doblin, Ph.D., founder and executive director of MAPS

Amanda Feilding, Director of the Beckley Foundation

And dozens of other experts discussed ayahuasca, ibogaine, LSD, MDMA, psilocybin, and salvia divinorum.